Robert A Lipper

Title: The Innovative Contributions of Robert A. Lipper

Introduction

Robert A. Lipper is a notable inventor based in Pennington, NJ (US). He has made significant contributions to the pharmaceutical industry, particularly in the development of novel dosage forms. With a total of 3 patents to his name, Lipper's work has had a meaningful impact on medication delivery systems.

Latest Patents

Lipper's latest patents include a groundbreaking invention for a unitary pharmaceutical dosage form. This innovative product combines efavirenz, emtricitabine, and tenofovir DF into a multicomponent unitary oral dosage form. In this formulation, component 1 consists of tenofovir DF, optionally including emtricitabine, while component 2 comprises efavirenz. The components are designed to be in a stabilizing configuration, with preferred embodiments utilizing dry granulation for component 1.

Career Highlights

Robert A. Lipper has worked with prominent companies in the pharmaceutical sector, including Bristol-Myers Squibb and Gilead Sciences, Inc. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.

Collaborations

Lipper has collaborated with esteemed colleagues such as Terrence C. Dahl and Munir A. Hussain. These partnerships have further enhanced the innovative potential of his work.

Conclusion

Robert A. Lipper's contributions to pharmaceutical innovations demonstrate his commitment to improving medication delivery systems. His patents reflect a dedication to advancing healthcare through effective and stable pharmaceutical formulations.